Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Emergent Biosolutions (EBS)

Emergent Biosolutions Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:EBS
DateTimeSourceHeadlineSymbolCompany
10/05/202412:17GlobeNewswire Inc.Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024NYSE:EBSEmergent Biosolutions Inc
01/05/202421:57GlobeNewswire Inc.Emergent BioSolutions Reports First Quarter 2024 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
01/05/202421:10GlobeNewswire Inc.Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial PositionNYSE:EBSEmergent Biosolutions Inc
01/05/202416:03GlobeNewswire Inc.Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to NaloxoneNYSE:EBSEmergent Biosolutions Inc
30/04/202422:26GlobeNewswire Inc.Emergent BioSolutions Announces Amendment to its Existing Credit FacilityNYSE:EBSEmergent Biosolutions Inc
22/04/202413:05GlobeNewswire Inc.Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024NYSE:EBSEmergent Biosolutions Inc
01/04/202413:00GlobeNewswire Inc.Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech ExecutiveNYSE:EBSEmergent Biosolutions Inc
28/03/202412:15GlobeNewswire Inc.Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCANĀ® Nasal Spray to Help Save Lives from the Ongoing Opioid CrisisNYSE:EBSEmergent Biosolutions Inc
25/03/202412:05GlobeNewswire Inc.Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing FacilityNYSE:EBSEmergent Biosolutions Inc
08/03/202421:21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EBSEmergent Biosolutions Inc
08/03/202401:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
06/03/202421:31GlobeNewswire Inc.Emergent BioSolutions Reports Fourth Quarter 2023 Financial ResultsNYSE:EBSEmergent Biosolutions Inc
06/03/202421:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
06/03/202411:02IH Market NewsU.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices ClimbNYSE:EBSEmergent Biosolutions Inc
04/03/202423:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
04/03/202423:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
04/03/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
29/02/202412:00GlobeNewswire Inc.Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024NYSE:EBSEmergent Biosolutions Inc
28/02/202401:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
28/02/202401:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EBSEmergent Biosolutions Inc
21/02/202412:25Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
21/02/202412:00GlobeNewswire Inc.Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEONYSE:EBSEmergent Biosolutions Inc
11/01/202412:41Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
09/01/202413:40Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
09/01/202412:30GlobeNewswire Inc.Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024NYSE:EBSEmergent Biosolutions Inc
27/12/202311:08IH Market NewsWall Street Highlights: Apple Appeals Watch Ban, Tesla to Launch Updated Model Y, and MoreNYSE:EBSEmergent Biosolutions Inc
11/12/202322:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:EBSEmergent Biosolutions Inc
11/12/202312:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EBSEmergent Biosolutions Inc
28/11/202312:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:EBSEmergent Biosolutions Inc
28/11/202311:59GlobeNewswire Inc.Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUSā„¢ (Anthrax Vaccine Adsorbed, Adjuvanted)NYSE:EBSEmergent Biosolutions Inc
 Showing the most relevant articles for your search:NYSE:EBS